Novel ocular antihypertensive compounds in clinical trials
June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology Clinical Research, Allergan, Inc, Irvine, CA, USAIntroduction: Glaucoma is a multifactorial disease characterized by progressive optic nerve injury and visual field defects. Elevated intraocular pres...
Guardado en:
Autores principales: | Chen J, Runyan SA, Robinson MR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ac057ef8196465d972e355602027be1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial
por: Patane MA, et al.
Publicado: (2011) -
A novel educational tool for teaching ocular ultrasound
por: Mustafa MS, et al.
Publicado: (2011) -
Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
por: Sedghipour MR, et al.
Publicado: (2012) -
Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
por: Sharma S, et al.
Publicado: (2015) -
Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella F, et al.
Publicado: (2012)